Daily Trade

The meme stock wave that sent Senseonics (NYSEMKT:SENS) stock higher has come and gone. Yet so far, it hasn’t pulled back in the way other stocks popular with Reddit traders have done. After its slide in July to under $2 per share, the medical technology play has partially bounced back, and today trades for around

Requiring that schoolchildren get vaccinated for COVID-19 “is a good idea,” Dr. Anthony Fauci said Sunday. While acknowledging that a vaccine mandate for kids would likely be controversial, President Joe Biden’s top pandemic adviser told CNN’s “State of the Union” that the benefits would far outweigh the risks. “I believe that mandating vaccines for children

Over the next 20 years, electric vehicles are going to take over the world. We all know this. Every investor, analyst, and financial media personality understands the enormous disruption coming to the multi-trillion-dollar mobility industry – and they all see it as the “investment opportunity of a lifetime.” Make no mistake. It is – but

Last fall, as large school systems across the country announced they wouldn’t be bringing students back to school in person, parents worried about the impact on their children’s educational progress and their own ability to work. Some clamored to get students back into school buildings. Others — if they could afford it — sought alternatives

Investors in electric vehicle battery hopeful QuantumScape (NYSE:QS) stock are not having a good year so far in 2021. QS stock now is near $22, down close to 75% year-to-date (YTD). The record high of $132.73 hit in late December 2020 seems far away in the rearview window. Source: Michael Vi / Shutterstock.com Leading automakers

Dear Moneyist, We just lost my 60-year-old uncle to dementia. He struggled with drugs during his early years, and as a result, my mom raised his daughter. Once he became sober, we were all very close, and we did our best to provide care for him.  His official cause of death was preventable — the

Meme stocks aren’t going anywhere anytime soon. One of the most interesting trends to emerge during the pandemic, this subcategory of stocks is generating a lot of interest, especially from retail investors. And that has led to a sharp increase of buying into companies with high short ratios. This is traditional investing turned upside down.

Your calendar may not yet have taken note, so let me be the first to inform you that fall has officially arrived. Not the season that begins this year on Sept. 22. Rather, the fall that begins when Starbucks SBUX, +0.70% starts peddling its autumn beverages. This year, the coffee chain kicked things off on

Earlier this year, General Electric (NYSE:GE) stock surged from a split-adjusted $50 per share to as much as $115.36 per share. The surge was mostly due to the Covid-19 “reopening” trade, along with success with its turnaround. Yet in recent months, shares in the industrial conglomerate have traded sideways. Source: Sundry Photography / Shutterstock.com Its

Cristiano Ronaldo and Manchester United MANU, +5.84% have reached an agreement that will put Ronaldo back on the Old Trafford pitch he plied from 2003 to 2009, the club announced. Ronaldo, who had been playing for Italian team Juventus FC, is set to return to the storied English Premier League club pending the completion of

Is going long Palantir (NYSE:PLTR) stock a bet on the big data dynamo continuing to knock things out of the park? Or is it a bet that the “growth at any price” environment that the market continues to be in will stay intact? The answer is a little bit of Column A, but mostly Column

Oil and natural-gas futures rose Friday, and were on track for strong weekly gains, after Tropical Storm Ida formed in the Caribbean and was on track to threaten the U.S. Gulf Coast. Tropical Storm Ida prompted a hurricane watch for New Orleans and an emergency declaration for the state of Louisiana as it pushed across

Dear MarketWatch,“Now’s the time to sell!” This is what we all keep hearing. As a homeowner in Northern Arizona, we would be looking to make a nice profit if we were to sell our home. But then what? Would that possibly make an impact if our next move is San Diego? We have dreamed of

The shining momentum for ContextLogic (NASDAQ:WISH) came and left in a hurry in June. Meme traders, where traders depicted stock buys with an image and a few words, lifted WISH stock. After ContextLogic posted results on August 12, any positive momentum all but evaporated. That is bad news for speculators, who thrive on trading volume.

One of the best things about being a hypergrowth investor is that I get to constantly study the world of tomorrow. In so doing, I’m always uncovering exciting new investment trends oozing with potential. And just last week, I uncovered a booming tech industry that I’m willing to bet you’ve never heard of before. Yet,

The number of COVID-19 hospitalizations in the U.S. has been slowly ticking up, and new data shows that 100,000 people are currently hospitalized with COVID-19, a figure that is on track with hospitalizations over the winter. The rapid spread of the delta variant, combined with the rollback of mitigation measures like social distancing and mask

The Original BARK Company (NYSE:BARK) would be the ideal stock for me as a dog lover if two conditions were met unconditionally. First and foremost, if I were living in the U.S. And second, if I was an investor acting on emotions, getting carried away by the company and its fancy products instead of doing

Federal regulators are likely to approve a COVID-19 booster shot for vaccinated adults starting at least six months after the previous dose rather than the eight-month gap they previously announced, a person familiar with the plans said, as the Biden administration steps up preparations for delivering boosters to the public. Data from vaccine manufacturers and other

While Canada becoming the first G7 nation to legalize recreational marijuana represented a boon for cannabis firms like Tilray (NASDAQ:TLRY), the long-term goal has always been breaking into the U.S. Let’s face facts. With a population of under 38 million, Canada just doesn’t have the economic clout that stakeholders of TLRY stock are looking for.

Johnson & Johnson is the latest drug maker to make the case that an extra dose of its COVID-19 shot can help boost antibody levels—by at least nine times that of the levels recorded 28 days after initial vaccination. J&J JNJ, -0.60% has been quiet about booster shots, especially compared with the public comments in